Yang, Yang
Liu, Tian
Liao, Che-Yi
Lee, Sun Ju
Keyvanshokooh, Esmaeil
Shao, Hui
Weber, Mary Beth
Pasquel, Francisco J.
Garcia, Gian-Gabriel P.
Funding for this research was provided by:
National Institutes of Health (1OT2OD032581)
National Institutes of Health (1OT2OD032581)
National Institutes of Health (1OT2OD032581)
National Institutes of Health (1OT2OD032581)
National Institutes of Health (1OT2OD032581)
National Institutes of Health (1OT2OD032581)
National Institutes of Health (1OT2OD032581)
National Institutes of Health (1OT2OD032581)
National Institutes of Health (1OT2OD032581)
Georgia Center for Diabetes and Translation Research (NIH/NIDDK P30DK111024)
Georgia Center for Diabetes and Translation Research (NIH/NIDDK P30DK111024)
Georgia Center for Diabetes and Translation Research (NIH/NIDDK P30DK111024)
Article History
Received: 6 November 2025
Accepted: 17 March 2026
First Online: 31 March 2026
Declarations
:
: All research in this manuscript has been performed in accordance with the Declaration of Helsinki and approved by the Institutional Review Board at the Georgia Institute of Technology (Protocol No. H22333). This study analyzes data from the All of Us Research Program, which uses a centralized, electronic informed consent (eConsent) process. It is modular (Primary Consent, HIPAA Authorization, and Genomics Consent) and uses multimedia tools like short videos to ensure participant understanding. Most importantly, it includes a “teach-back” quiz that participants must pass to confirm they understand the voluntary nature of the study. The details of this consent process are provided on their web page ( ).
: This manuscript has been read and its submission approved by all authors.
: FJP reported receiving grants through the institution from Insulet, Tandem Diabetes Care, Ideal Medical Technologies, Novo Nordisk, and Dexcom; receiving consulting fees from Dexcom; receiving consulting fees to the institution from Insulet. All other authors have no competing interests to declare.